DAFTAR PUSTAKA
1. Simanungkalit AP, Supit AI. Karakteristik dan perjalanan penyakit pasien infark miokard akut dengan elevasi segmen ST ( IMA-EST ) tanpa tatalaksana reperfusi pada rumah sakit perifer. Intisari Sains Medis.
2022;13(1):148–52.
2. Hanna EB, Glancy DL, Saucedo JF. Antiplatelet and anticoagulant therapies in acute coronary syndromes. Cardiovasc Drugs Ther.
2010;24(1):61–70.
3. Riley L, Cowan M, Carlos M. World Health Organization.
Noncommunicable disease Progress Monitor 2020. Geneva: WHO;2020. p.
89
4. BPPK Kemenkes. Laporan riset kesehatan dasar penyakit jantung koroner . 2018. Jakarta: Badan Penelitian dan Pengembangan Kesehatan Kemenkes RI; 2018. p. 154-63
5. Juzar DA, Danny SS, Irmalita, Widyantoro B, Rossimarina V, et al.
Pedoman Tatalaksana Sindrom Koroner Akut Edisi Ketiga. Jakarta:
Inaheart. 2015. p. 1-10
6. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. Eur Heart J.
2012;33(20):2551–67
7. Anderson JL. ACCF/AHA guideline for the management of ST-elevation myocardial infarction: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013;127(4):529–55
8. Almutlaq BA, Alanqari A, Khalid R, Alshammari KT, Alshammari HA, Almubrad J, et al. Risk Factors Associated with Acute Coronary Syndrome in Northern Saudi Arabia. J Cardiol Curr Res. 2017;8(3):1–5
9. Wagyu EA. Gambaran Pasien Infark Miokard Dengan Elevasi St (Stemi) Yang Dirawat Di Blu Rsup Prof. Dr. R. D. Kandou Manado Periode Januari 2010 Sampai Desember 2010. e-CliniC. 2013;1(3)
10. Alwi I. Infark miokard akut dengan elevasi st. In: Sudoyo A, Setyohadi B, Alwi I, Simadibrata M, editors. Buku Ajar Ilmu Penyakit Dalam Jilid 1.
edisi 6. Jakarta: Interna Publishing; 2014. p. 1741–56
11. Guyton A, Hall J. Buku ajar fisiologi kedokteran. Jakarta: EGC; 2007. p.
85-6
12. Sudoyo A, Alwi I, Setiyohadi B. Infark miokard akut dengan elevasi st. 6th ed. Jakarta: Interna Publishing; 2010. p. 1741–56
13. Suryohudoyo P. Kapita selekta ilmu kedokteran molekuler. Jakarta: CV Sagung Seto; 2007. p. 31–47
14. Price S, Wilson L. Patofisiologi: konsep klinis proses-proses penyakit. 6th ed. Jakarta: Penerbit buku kedokteran EGC; 2005. p. 585–88
15. Zafari AM. Myocardial infarction. Medscape [Internet]; 2015. p. 9–10 16. Lily LS. Pathopysiology of heart disease. 5 th ed. Philadelphia; Walters
Kluwer. 2011. p. 161–80
17. Susilo C, Sujuti H. Hubungan luas infark miokard (berdasar skor selvester) dengan respon nyeri dada pada pasien sindrom koroner akut. JIK.
2013;1(49):91–7
18. Muhammad G, Ardhianto P. Profil Faktor Risiko Atherosklerosis Pada Kejadian Infark Miokard Akut Dengan St-Segment Elevasi Di Rsup Dr Kariadi Semarang. Jurnal Kedokteran Diponegoro. 2015;4(4):849–58 19. Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD,
Hahn EJ, et al. Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;
140(11): 596–646
20. Gray H, Dawkins K, Simpson L, Morgan J. Lecture notes cardiology. 4th ed. Jakarta: Erlangga Medical Series; 2001. p. 107–50
21. Brown T. Penyakit aterosklerotik koroner. 6th ed. Jakarta: EGC; 2006. p.
580–87
22. Wilar GI, Panda AL, Rampengan SH. Pengamatan 6 Bulan Terhadap Kejadian Kardiovaskular Mayor Pada Pasien Dengan Infark Miokard Akut Dengan Elevasi Segmen St (Stemi) Di Rsup Prof. Dr. R. D. Kandou Manado Periode Januari-Desember 2017. Jurnal Medik dan Rehabilitasi.
2019;1(3):1-8
23. Lukito A, Hameiwaty E, Hustrini N, Kosasih A, Soenarta A. Konsensus penatalaksanaan hipertensi 2019. Jakarta: Indonesian of Hypertension;
2019. p. 10–21,33–46
24. Christofferson R. Acute Myocardial Infarction. 3rd ed. Philadelphia;
Lippincot Williams & Wilkins. 2009. p. 1-28
25. Perhimpunan Dokter Spesialis Kardiovaskuler Indonesia. Pedoman Tatalaksana Sindrom Koroner Akut. PERKI. 2015;(3):38,48-9
26. Perhimpunan Dokter Spesial Kardiovaskuler Indonesia. Panduan prevensi penyakit kardiovaskuler aterosklerosis. PERKI. 2015;(3): 49-58
27. Wagiu MB, Pangemanan JA, Panda AL. Hubungan derajat merokok dengan kejadian infark miokard di RSUP Prof. Dr. R. D. Kandou Manado.
e-CliniC. 2016;4(2):1-7
28. Amsterdam EA, Wenger NK, Brindis RG, Casey DE, Ganiats TG, Holmes DR, et al. Guideline for the management of patients with non-st-elevation acute coronary syndromes: A report of the American college of cardiology/American heart association task force on practice guidelines.
Circulation. 2014;130(25):344–426
29. Stary H, Chandler A, Dinsmore R, Fuster V, Glagov S, Insull W. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. Circulation. 1995;92:1355–74
30. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J.
2018;39(2):119–77
31. Gulati M, Levy PD, Mukherjee D, Amsterdam E, Bhatt DL, Birtcher KK, et al. Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.Circulation. 2021. 144(22):368- 454
32. Capodanno D, Patel A, Dharmashankar K, Ferreiro JL, Ueno M, Kodali M, et al. Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery disease. Circulation.
2011;4(2):180–7
33. Sherwood MW, Wiviott SD, Peng SA, Roe MT, Delemos J, Peterson ED, et al. Early clopidogrel versus prasugrel use among contemporary STEMI and NSTEMI patients in the US: insights from the National Cardiovascular Data Registry.Journal of the American Heart Association. 2014;3(2):1-9 34. Wiviott SD, Antman EM, Gibson CM, Montalescot G, Riesmeyer J,
Weerakkody G, et al. Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infar. Journal of the American Heart Association. 2006;152(4):627-35
35. Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. Guidelines on myocardial revascularization. Europe Heart Journal.
2019;40(2):87–165
36. Boersma E. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in- hospital fibrinolysis in acute myocardial infarction patients. Europe Heart Journal. 2006;27(7):779–88
37. Muhibbah WA, Agustina R, Oskilliandri. Karakteristik pasien sindrom koroner akut pada pasien rawat inap ruang tulip di RSUD Ulin Banjarmasin. Indonesian Journal of Health Sciences. 2019;3(1):6-12 38. Antoniades L, Christodoulides T, Georgiou P, Hadjilouca C, Christodoulou
E, Papasavas E, et al. Epidemiology of acute coronary syndromes in the Mediterranean Island of Cyprus (CYPACS study, Cyprus study of acute coronary syndromes). Hellenic J Cardiol. 2014; 55(2):139-49
39. Muhammad RM, Ardhianto P. Profil faktor risiko atherosclerosis pada kejadian infark miokard dengan st – segment elevasi di RSUP DR Kariadi Semarang. Media Medika Utama. 2015;4(4):849-58
40. Yusuf, S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated withmyocardial infarction in 52 countries (the INTERHEARTstudy): case-control study. Interheart. 2014; 145(23):1-16 41. Gordon T, Kannel WB, Hjortland MC, et al. Menopause and coronary heart
disease. The Framingham Study. Ann Intern Med. 2015;89(2):157-61 42. Rodgers JL, Jones J, Bolleddu SI, Vanthenapalli S, et al. Cardiovascular
risks associated with gender and aging. Journal of Cardiovascular development and disease. 2019;6(19):8-10
43. Dharmawan M, Hidayat LW, Tiluata LJ. Profil infark miokard akut dengan kenaikan segmen-st di ICCU RSUD Prof W. Z. Johannes Kupang, Nusa Tenggara Timur, Januari-April 2018. Jurnal Cermin Dunia Kedokteran.
2019;46(12):727-29
44. Pravitasari HF, Mahmuda INN, Jatmiko SW, et al. Hubungan tekanan darah, kolestrol total dan trigliserida terhadap pasien STEMI dan NSTEMI.
JMS. 2019;2(1):250-54
45. Willian B, Lacy PS, Thom SM, et al. Differential Impact of Blood Pressure–Lowering Drugs on Central Aortic Pressure and Clinical Outcomes. Circulation AHA. 2006;113(1):1213-15
46. Vinnu R. Karakteristik klinis pasien infark miokard akut dengan elevasi segmen ST (IMA-EST) pada pasien rawat inap di RSUD Kabupaten Buleleng pada tahun 2019-2020. 2022;4(1):21-30
47. Hakim AR, Muhani N. Hubungan dislipidemia, hiperensi, riwayat diabetes melitus terhadap kejadian sindroma koroner akut pada pasien poli jantung di RSUD Ahmad Yani Metro Lampung 2019. Jurnal Ilmu Kedokteran dan Kesehatan. 2020;7(2):421-22
48. Long D, et al. Harrison's principles of internal medicine. 18th Ed. New York: McGraw-Hill. 2011. p. 2624-31
49. Wardhani RL. Mahmudah N, Nurhayani, et al. Hubungan antara nilai rasio kolestrol total terhadap HDL dan kada glukosa darah pada pasien penderita NSTEMI dan STEMI. Publikasi Ilmiah. 2021;4(1):367-68
50. Torry SRV, Panda L, Ongkowijaya J. Gambaran faktor risiko penderita sinrom koroner akut. e-Clinic. 2014;2(1):5-7
51. Rosmiatin M. Analisis faktor-faktor risiko terhadap kejadian penyakit jantung koroner pada wanita lanjut usia di RSUPN Dr. Cipto Mangunkusumo Jakarta [Thesis]. Jakarta: Universitas Indonesia; 2012. p.
63
52. Wahrenberg A. Magnusson PKE, Discacciati A, et al. Family history of coronary artery disease is associated with acute coronary syndrome in 28,188 chest pain patients. Europena Heart Journal. 2020;9(7):741-47
